Rifampicin-induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report

被引：1
|
作者：
Moussa, Chirine [1 ,2 ,5 ]
Esbaa, Samia [1 ,2 ]
Rouis, Houda [1 ,2 ]
Sellami, Nada [2 ,3 ]
Hajji, Meriam [2 ,3 ]
Houcine, Yoldez [2 ,4 ]
Khattab, Amel [1 ]
Khouaja, Ibtihel [1 ]
Zendah, Ines [1 ,2 ]
Maalej, Sonia [1 ,2 ]
机构：
[1] Abderrahmen Mami Hosp, Pneumol Dept 1, Ariana, Tunisia
[2] El Manar Univ, Fac Med Tunis, Tunis, Tunisia
[3] Charles Nicolle Hosp, Internal Med A, Tunis, Tunisia
[4] Abderrahmen Mami Hosp, Pathol Dept, Ariana, Tunisia
[5] Abderrahmen Mami Hosp, Pneumol Dept 1, Ariana 2080, Tunisia
来源：
RESPIROLOGY CASE REPORTS | 2023年 / 11卷 / 08期
关键词：
acute kidney injury; acute renal failure; acute tubulointerstitial nephritis; rifampicin; tuberculosis; ACUTE INTERSTITIAL NEPHRITIS;
D O I：
10.1002/rcr2.1190
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Drug-induced tubulointerstitial nephritis is an uncommon complication in patients on anti-tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41-years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.
引用
收藏
页数：5
相关论文
共 50 条
12345